Trinity Biotech (TRIB) Short-term Investments (2017 - 2025)
Trinity Biotech's Short-term Investments history spans 9 years, with the latest figure at $67000.0 for Q2 2025.
- On a quarterly basis, Short-term Investments fell 65.28% to $67000.0 in Q2 2025 year-over-year; TTM through Jun 2025 was $67000.0, a 65.28% decrease, with the full-year FY2024 number at $166000.0, down 6.74% from a year prior.
- Short-term Investments hit $67000.0 in Q2 2025 for Trinity Biotech, down from $166000.0 in the prior quarter.
- Over the last five years, Short-term Investments for TRIB hit a ceiling of $232000.0 in Q1 2024 and a floor of $67000.0 in Q2 2025.
- Historically, Short-term Investments has averaged $170923.1 across 4 years, with a median of $178000.0 in 2023.
- Biggest five-year swings in Short-term Investments: soared 52.86% in 2023 and later crashed 65.28% in 2025.
- Tracing TRIB's Short-term Investments over 4 years: stood at $128000.0 in 2022, then soared by 39.06% to $178000.0 in 2023, then fell by 6.74% to $166000.0 in 2024, then plummeted by 59.64% to $67000.0 in 2025.
- Business Quant data shows Short-term Investments for TRIB at $67000.0 in Q2 2025, $166000.0 in Q4 2024, and $190000.0 in Q3 2024.